Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part II. The antileukemic effect
Laske, Reiner, Schönenberger, Helmut und Holler, Eggehard (1989) Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part II. The antileukemic effect. Archiv der Pharmazie 322 (12), S. 857-862.Veröffentlichungsdatum dieses Volltextes: 12 Nov 2010 07:31
Artikel
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Archiv der Pharmazie | ||||
| Verlag: | Wiley | ||||
|---|---|---|---|---|---|
| Band: | 322 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 12 | ||||
| Seitenbereich: | S. 857-862 | ||||
| Datum | 1989 | ||||
| Zusätzliche Informationen (Öffentlich) | CAN 112:111625 1-6 Pharmacology 50-67-9 (5-Hydroxytryptamine); 51-61-6 (Dopamine); 51-65-0 (DL-4-Fluorophenylalanine); 51-67-2 (Tyramine); 56-12-2; 60-23-1 (Cysteamine); 61-54-1 (Tryptamine); 62-57-7 (2-Aminoisobutyric acid); 63-84-3 (DL-3,4-Dihydroxyphenylalanine); 64-12-0 (DL-p-Chloroamphetamine); 67-21-0 (DL-Ethionine); 70-78-0 (3-Iodo-L-tyrosine); 103-01-5 (N-Phenylglycine); 104-63-2 (N-Benzylethanolamine); 153-44-6 (beta -Methyl-DL-tryptophan); 153-91-3 (alpha -Methyl-DL-tryptophan); 299-26-3; 403-90-7 (DL-3-Fluorotyrosine); 405-39-0; 443-80-1; 456-88-2 (DL-3-Fluorophenylalanine); 500-44-7; 526-31-8; 536-33-4 (Ethionamide); 541-48-0 (DL-3-Aminobutyric acid); 543-38-4; 552-85-2; 587-20-2 (alpha -Methylhistidine); 621-44-3 (3-Nitro-L-tyrosine); 671-42-1 (DL-alpha -Amino-e-caprolactam); 687-51-4 (L-Leucinamide); 760-78-1 (DL-Norvaline); 951-55-3 (5-Methyl-DL-tryptophan); 979-92-0 (S-Adenosyl-L-homocysteine); 1113-41-3 (L-Penicillamine); 1132-26-9 (alpha -Methyl-DL-phenylalanine); 1138-80-3; 1149-26-4; 1464-42-2 (Seleno-DL-methionine); 1483-07-4 (Albizziin); 1955-68-6; 2021-58-1 (beta -2-Thienyl-DL-alanine); 2133-34-8 (L-Azetidine-2-carboxylic acid); 2260-12-0 (beta -Methyl-DL-phenylalanine); 2280-42-4 (DL-beta -Hydroxynorvaline); 2629-55-2 (DL-2-Fluorophenylalanine); 2697-61-2 (Selenocystamine); 2731-73-9 (L-beta -Chloroalanine); 2749-07-7 (alpha -Methyl-DL-methionine); 2792-72-5; 2799-07-7 (S-Trityl-L-cysteine); 2897-21-4 (DL-Selenocystine); 2899-37-8 (L-Methioninol); 2935-35-5 (L-alpha -Phenylglycine); 2936-69-8 (L-4-Thialysine); 3182-95-4 (L-Phenylalaninol); 3251-08-9; 3395-35-5 (DL-3,4-Dehydroproline); 3647-71-0 (N-Benzyl-2-phenylethylamine); 4144-02-9; 4350-09-8 (L-5-Hydroxytryptophan); 4746-36-5 (DL-4-Azaleucine); 4836-52-6 (L-Histidinol); 5034-68-4 (L-Tyrosinol); 6232-19-5 (beta -Cyano-L-alanine); 6645-45-0; 6829-40-9 (Aminomalonic acid diethyl ester); 7303-50-6 (DL-7-Azatryptophan); 7533-40-6 (L-Leucinol); 7695-56-9 (DL-threo-beta -Phenylserine); 7730-20-3 (DL-6-Fluorotryptophan); 10065-72-2 (L-Alanine methyl ester); 13004-62-1 (trans-2,6-Diaminohex-4-enoic acid); 14954-40-6; 16063-80-2; 16120-92-6; 16748-73-5 (L-Aspartic acid diamide); 17332-70-6 (7-Methyl-DL-tryptophan); 17463-43-3 (3,3,3-Trifluoro-DL-alanine); 17480-69-2 (N-Benzyl-D-amphetamine); 17781-05-4; 18625-03-1; 18865-31-1; 19461-04-2 (N-Benzyl-L-phenylalanine); 23220-52-2 (meso-2,3-Diaminosuccinic acid); 24629-25-2; 25125-92-2; 25631-05-4 (DL-4-Fluorotryptophan); 26340-83-0; 26988-72-7 (1-Methyl-DL-tryptophan); 28057-52-5 (L-Isoasparagine); 28143-91-1; 34592-47-7; 40172-05-2; 52153-41-0; 54542-13-1; 55779-32-3; 57601-68-0; 57734-57-3 (2-Aminomethylpyrrolidine); 60046-47-1; 65934-95-4 (Fenitropan); 75543-73-6; 80300-21-6; 80300-23-8; 91531-30-5 (Antineoplaston A10); 108321-88-6; 124081-74-9; 125293-76-7; 125293-77-8; 125293-79-0 (DL-2,6-Diphthalimidocaproic acid methyl ester); 125293-80-3; 125293-81-4; 125293-82-5; 125293-83-6; 125293-85-8; 125293-86-9; 125356-75-4; 125729-28-4 Role: BIOL (Biological study) (amino acid antagonist, aminoacyl tRNA synthetase inhibitory and antileukemic activities of); 52-90-4 (Cysteine); 56-40-6 (Glycine); 56-41-7 (L-Alanine); 56-84-8 (Aspartic acid); 56-85-9 (Glutamine); 56-86-0 (Glutamic acid); 70-47-3 (Asparagine); 71-00-1 (Histidine); 73-32-5 (Isoleucine); 74-79-3 (L-Arginine) Role: BIOL (Biological study) (antagonists, aminoacyl tRNA synthetase inhibitory and antileukemic activities of); 56-45-1 (L-Serine); 56-87-1 (L-Lysine); 60-18-4 (L-Tyrosine); 61-90-5 (L-Leucine); 63-68-3 (L-Methionine); 63-91-2 (L-Phenylalanine); 72-18-4 (L-Valine); 72-19-5 (L-Threonine); 147-85-3 (L-Proline) Role: BIOL (Biological study) (antagonists, aminoacyl-tRNA synthetase and antileukemia activities of); 9028-02-8 (Aminoacyl tRNA synthetase) Role: PROC (Process) (inhibition of, by amino acid antagonist, antileukemia activities of) | ||||
| Institutionen | Chemie und Pharmazie > Institut für Pharmazie > Entpflichtete oder im Ruhestand befindliche Professoren > Prof. Schönenberger | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | Amino acids Role: BIOL (Biological study) (antagonists, aminoacyl tRNA synthetase inhibitory and antileukemic activities of) Neoplasm inhibitors (leukemia, amino acid antagonists as, aminoacyl tRNA synthetase inhibition in relation to) amino acid antagonist antiproliferation tRNA synthetase | ||||
| Dewey-Dezimal-Klassifikation | 500 Naturwissenschaften und Mathematik > 540 Chemie | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| Dokumenten-ID | 17675 |
Bibliographische Daten exportieren
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric
Altmetric